Blood Plasma Derivatives Market Growing $44,333 Million, at a CAGR of 9.3% from 2017 to 2023

Logo

Portland, OR -- (SBWire) -- 06/13/2018 --Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), and immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III.

For More Info, Get Sample : https://www.researchbeam.com/blood-plasma-derivatives-market/request-sample

The global blood plasma derivatives market was valued at $23,613 million in 2016, and is projected to reach $44,333 million at a CAGR of 9.3% from 2017 to 2023. The major factor that contributes towards the growth of the blood plasma derivatives market is increase in prevalence of life-threatening diseases such as immunodeficiency disorders and hemophilia. Moreover, other factors boosting the market growth include increase in awareness for blood & plasma donation, rise in geriatric population, and high adoption of blood plasma derivatives products. However, high cost of treatment and risks of side effects associated with the use of plasma derivatives hamper the market growth. Conversely, development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market.

The global blood plasma derivatives market is segmented on the basis of type, application, end user, and region. Based on type, the market is fragmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The applications covered in the study include hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand's Disease (vWD), and other application. By end user, the market is classified into hospitals, clinics, and other end users. Region wise, it is analyzed for North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

- The study provides an in-depth analysis of the global blood plasma derivatives market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key market segments

By Type

- Albumin
- Factor VIII
- Factor IX
- Immunoglobulin
- Hyperimmune Globulin
- Others

Enquire About Report : https://www.researchbeam.com/blood-plasma-derivatives-market/enquire-about-report

By Application

- Hemophilia
- Hypogammaglobulinemia
- Immunodeficiency Diseases
- von Willebrand's disease (vWD)
- Other Application

By End User

- Hospitals
- Clinics
- Other End Users

By Region

- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

- Grifols, S.A.
- SK Plasma Co., Ltd.
- Fusion Health Care Pvt. Ltd.
- Biotest AG
- Green Cross Corporation
- Baxter International Inc.
- LFB S.A.
- Octapharma AG
- CSL Limited
- Shire Plc.

Also Request For Discount : https://www.researchbeam.com/blood-plasma-derivatives-market/purchase-enquiry

Table Of Content

- CHAPTER 1: INTRODUCTION
- CHAPTER 2: EXECUTIVE SUMMARY
- CHAPTER 3: MARKET OVERVIEW
- CHAPTER 4: BLOOD PLASMA DERIVATIVES MARKET, BY TYPE
- CHAPTER 5: BLOOD PLASMA DERIVATIVES MARKET, BY APPLICATION
- CHAPTER 6: BLOOD PLASMA DERIVATIVES MARKET, BY END USER
- CHAPTER 7: BLOOD PLASMA DERIVATIVES MARKET, BY REGION
- CHAPTER 8: COMPANY PROFILES

About Research Beam
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

Media Relations Contact

Dhanajay Potale
Manager
+1-971-202-1575
https://www.researchbeam.com/

View this press release online at: http://rwire.com/994178